These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11407134)

  • 1. Equianalgesic dosing of transdermal fentanyl.
    Spagnolo L
    Am J Hosp Palliat Care; 2001; 18(2):84. PubMed ID: 11407134
    [No Abstract]   [Full Text] [Related]  

  • 2. Converting to transdermal fentanyl: avoidance of underdosing.
    Bradley AM; Valgus JM; Bernard S
    J Palliat Med; 2013 Apr; 16(4):409-11. PubMed ID: 23477303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
    Clemens KE; Klaschik E
    Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transdermal opioid administration: the pain plaster].
    Vecht CJ; Sillevis Smitt PA
    Ned Tijdschr Geneeskd; 1997 Apr; 141(17):821-3. PubMed ID: 9221362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of transdermal morphine and fentanyl pluronic lecithin organogel administration in dogs.
    Krotscheck U; Boothe DM; Boothe HW
    Vet Ther; 2004; 5(3):202-11. PubMed ID: 15578452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inconsistencies in opioid equianalgesic ratios: clinical and research implications.
    O'Bryant CL; Linnebur SA; Yamashita TE; Kutner JS
    J Pain Palliat Care Pharmacother; 2008; 22(4):282-90. PubMed ID: 21923312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The absence of 'cross-tolerance' when switching from oral morphine to transdermal fentanyl.
    Johnson S; Faull C
    Palliat Med; 1997 Nov; 11(6):494-5. PubMed ID: 9519176
    [No Abstract]   [Full Text] [Related]  

  • 8. More on the conversion of transdermal fentanyl to morphine.
    Storey P
    J Pain Symptom Manage; 1995 Nov; 10(8):581-2. PubMed ID: 8594116
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharma clinics. How I treat...or preventing pain with "patches"].
    Piérard GE
    Rev Med Liege; 1998 Oct; 53(10):586-7. PubMed ID: 9857751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthrough strong opioid analgesia prescription in patients using transdermal fentanyl admitted to a hospice.
    Lawrie I; Lloyd-Williams M; Waterhouse E
    Am J Hosp Palliat Care; 2003; 20(3):229-30. PubMed ID: 12785045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fentanyl by buccal administration. Fifty to hundred times stronger than morphine against pain].
    Taeron C
    Rev Infirm; 2002 Sep; (83):47-9. PubMed ID: 12380268
    [No Abstract]   [Full Text] [Related]  

  • 13. Early conversion from oral morphine to transdermal fentanyl in patients with cancer pain.
    Tani M; Fuku A; Terashita S; Kashiwagi H; Yukawa H; Yamaue H
    Hepatogastroenterology; 2008; 55(86-87):1545-8. PubMed ID: 19102339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine.
    Radbruch L; Sabatowski R; Loick G; Kulbe C; Kasper M; Grond S; Lehmann KA
    Palliat Med; 2000 Mar; 14(2):111-9. PubMed ID: 10829145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thinks transdermal fentanyl patches are dangerous.
    Glassman A
    J Am Vet Med Assoc; 2002 Jul; 221(1):31; author reply 31-2. PubMed ID: 12420814
    [No Abstract]   [Full Text] [Related]  

  • 16. Patient-controlled transdermal fentanyl hydrochloride vs intravenous morphine pump for postoperative pain: a randomized controlled trial.
    Viscusi ER; Reynolds L; Chung F; Atkinson LE; Khanna S
    JAMA; 2004 Mar; 291(11):1333-41. PubMed ID: 15026400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An alternative algorithm for dosing transdermal fentanyl for cancer-related pain.
    Breitbart W; Chandler S; Eagel B; Ellison N; Enck RE; Lefkowitz M; Payne R
    Oncology (Williston Park); 2000 May; 14(5):695-705; discussion 705, 709-17. PubMed ID: 10853461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Direct conversion from low-dose morphine to transdermal fentanyl: efficacy for cancer pain and quality of life].
    Yamazaki M; Aoki T; Tachibana M; Akashi T
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):217-21. PubMed ID: 16484859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of transdermal fentanyl versus epidural morphine for analgesia in dogs undergoing major orthopedic surgery.
    Robinson TM; Kruse-Elliott KT; Markel MD; Pluhar GE; Massa K; Bjorling DE
    J Am Anim Hosp Assoc; 1999; 35(2):95-100. PubMed ID: 10102175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the bioequivalence of two transdermal fentanyl systems following single and repeat applications.
    Sathyan G; Guo C; Sivakumar K; Gidwani S; Gupta S
    Curr Med Res Opin; 2005 Dec; 21(12):1961-8. PubMed ID: 16368047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.